TGTX

48.74

1.67% 0.80

Dopo l'orario di chiusura: 48.50 -0.24 -0.49%

Tg Therapeutics Inc (TGTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TGTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$47.94

Aprire:

$47.27

Volume 24 ore:

1.07M

Relative Volume:

0.46

Capitalizzazione di mercato:

$7.46B

Reddito:

$700.35M

Utile/perdita netta:

$461.90M

Rapporto P/E:

16.98

EPS:

2.8696

Flusso di cassa netto:

$-14.19M

1 W Prestazione:

-2.05%

1M Prestazione:

-11.20%

6M Prestazione:

+71.02%

1 anno Prestazione:

+75.51%

Intervallo 1D:

$47.27

$48.92

Intervallo di 1 settimana:

$47.27

$50.55

Portata 52W:

$26.76

$59.30

Tg Therapeutics Inc Stock (TGTX) Company Profile

Nome

Tg Therapeutics Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

(212) 554-4484

Indirizzo

2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY

Dipendente

399

Cinguettio

@TGTherapeutics

Prossima data di guadagno

2026-08-03

Ultimi documenti SEC

TGTX's Discussions on Twitter

Compare TGTX vs VRTX, REGN, ARGX, RVMD, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TGTX Tg Therapeutics Inc	48.74	7.58B	700.35M	461.90M	-14.19M	2.8696
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-06	Ripresa	H.C. Wainwright	Buy
2025-07-10	Ripresa	Goldman	Neutral
2024-10-29	Iniziato	TD Cowen	Buy
2023-08-02	Aggiornamento	Goldman	Sell → Neutral
2023-06-26	Ripresa	Jefferies	Buy
2022-05-20	Iniziato	BofA Securities	Underperform
2022-02-23	Reiterato	B. Riley Securities	Buy
2021-11-15	Downgrade	Goldman	Neutral → Sell
2021-04-20	Iniziato	Goldman	Neutral
2021-04-19	Reiterato	H.C. Wainwright	Buy
2020-09-01	Iniziato	JP Morgan	Overweight
2020-08-11	Reiterato	H.C. Wainwright	Buy
2020-06-05	Iniziato	Evercore ISI	Outperform
2020-01-17	Reiterato	H.C. Wainwright	Buy
2019-11-27	Ripresa	B. Riley FBR	Buy
2019-02-06	Ripresa	Jefferies	Buy
2018-09-25	Downgrade	Raymond James	Strong Buy → Outperform
2018-03-09	Reiterato	B. Riley FBR, Inc.	Buy
2017-12-01	Ripresa	B. Riley FBR, Inc.	Buy
2017-11-14	Ripresa	H.C. Wainwright	Buy
2017-04-25	Iniziato	Jefferies	Buy
2017-03-06	Reiterato	FBR & Co.	Outperform
2016-10-06	Ripresa	Brean Capital	Buy
2016-05-27	Iniziato	SunTrust	Buy
2015-12-01	Iniziato	FBR Capital	Outperform
2015-09-09	Iniziato	Raymond James	Strong Buy
2015-08-12	Ripresa	H.C. Wainwright	Buy
2015-06-19	Reiterato	Brean Capital	Buy
2014-12-11	Reiterato	ROTH Capital	Buy
2014-12-10	Reiterato	ROTH Capital	Buy

Mostra tutto

Tg Therapeutics Inc Borsa (TGTX) Ultime notizie

Aug 15, 2026

TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits

Aug 15, 2026

Aug 14, 2026

TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits

Aug 14, 2026

Aug 13, 2026

US High Growth Tech Stocks To Watch: 3 Top Picks - Sahm

Aug 13, 2026

TGTX Stock Slips After Earnings – But CEO's $1B Briumvi Outlook Keeps Retail Bullish - Stocktwits

Aug 13, 2026

Trading Systems Reacting to (TGTX) Volatility - Stock Traders Daily

Aug 13, 2026

Bank of America Corp DE Purchases 610,195 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat

Aug 13, 2026

Assenagon Asset Management S.A. Lowers Stock Position in TG Therapeutics, Inc. $TGTX - marketbeat.com

Aug 13, 2026

Aug 12, 2026